News

Learn how and why East Indian Sandalwood Oil (EISO) is making international headlines as a unique, non-substitutable botanical drug candidate.

TFS to Acquire US Pharmaceutical Partners to Capture Downstream Revenues from Product Sales

Posted on

Highlights: TFS to acquire its US-based pharmaceutical partners ViroXis Corporation and Santalis Pharmaceuticals for a combined minimum price of US$23.4 million, comprising US$1.5 million in cash and US$21.9 million in TFS shares. The acquisitions will extend TFS’s vertically integrated strategy from “soil to oil” to “soil to oil to shelf” as ViroXis and Santalis are well advanced in the formulation, […]Read More TFS to Acquire US Pharmaceutical Partners to Capture Downstream Revenues from Product Sales